ICP is a liver condition specific to pregnancy affecting 0.5–0.6% of pregnancies in Australia.
Aims
to review the SOMANZ guidelines and extrapolate information relevant to midwives proving care for women with ICP.
Findings
Multidisciplinary input is essential in caring for women with ICP and their families. Non-fasting TSBA samples ≥19 µmol/L are diagnostic in the presence of pruritus. Peak TSBA denotes the severity of the disease. Increased risk of stillbirth is small when peak TSBA ≥100 µmol/L.
Conclusion
Midwives play an essential role in supporting women with ICP helping them navigate complex appointments and manage the pruritus and concomitant issues.
JiangZHQiuZDLiuWW, et al.Intrahepatic cholestasis of pregnancy and its complications. Analysis of 100 cases in Chongqing area. Clin Med J (Engl)1986; 99: 957–960.
2.
GeneesVWilliamsonC. Intrahepatic cholestasis of pregnancy. World J Gastroenterol2009; 15: 2049–2066.
3.
Royal College of Obstetricians and Gynaecologists. Intrahepatic cholestasis of pregnancy (Green-top Guideline No. 43) RCOG 2022. London.
MaratheJALimWHMetzMP, et al.A retrospective cohort review of intrahepatic cholestasis of pregnancy in a South Australian population. Eur J Obstet Gynecol Reprod Biol2017; 218: 33–38.
7.
GardinerFWMcCuaigRArthurC, et al.The prevalence of pregnancy outcomes in intrahepatic cholestasis of pregnancy: a retrospective clinical audit review. Obstet Med2019; 12: 123–128.
LefebvrePCariouBLienF, et al.Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev2009; 89: 147–191.
10.
ReyesHGonzalezMCRibaltaJ, et al.Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med1978; 88: 487–493.
11.
GlantzAMarschallHUMattssonLA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology2004; 40: 467–474.
12.
AbedinPWeaverJBEggintonE. Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health1999; 4: 16.
13.
ElorantaMLHeinonenSMononenT, et al.Risk of obstetric cholestasis in sisters of index patients. Clin Genet2001; 60: 42–45.
14.
DixonPHLevineAPCebolaI, et al.GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements. Nat Commun2022; 13: 4840.
15.
GonzalezMCReyesHArreseM, et al.Intrahepatic cholestasis of pregnancy in twin pregnancies. J Hepatol1988; 9: 84–90.
16.
ChunFWen-juanLHeR-H, et al.Impacts of different methods of conception on the perinatal outcome of intrahepatic cholestasis of pregnancy in twin pregnancies. Sci Rep2018; 8: 3985.
17.
MarschallHUWilkstrom ShemerELudvigssonJF, et al.Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study. Hepatology2013; 58: 1385–1391.
18.
BergBHelmGPetersohnL, et al.Cholestasis of pregnancy. Clinical and laboratory studies. Acta Obstet Gynecol Scand1986; 65: 107–113.
19.
ICP Support. Information for health care professionals, www.icpsupport.org (accessed 24 January 2024).
20.
McKibbenAChambersJWilliamsonC, et al.Patient perspectives on pruritus in intrahepatic cholestasis of pregnancy: a multinational survey. In: Digital International Liver Conference, 2021.
21.
MitchellALOvadiaCSyngelakiA, et al.Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy with biochemical markers: case-control and cohort study. BJOG2021; 128: 1635–1644.
22.
BertiSAmatoLChianriniC, et al.An itching and excoriated dermatosis during intrahepatic cholestasis of pregnancy. SkinMed2005; 4: 248–249.
23.
MarkusCCoatSMarschallH-U, et al.The BACH project protocol: an international multicentre total bile acid comparison and harmonisation project and sub-study of the TURRIFIC randomised trial. Clin Chem Lab Med2021; 59: 1921–1929.
24.
ChappellLCBellJLSmithA, et al.Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet2019; 394: 849–860.
25.
DannATKenyonAPWierzbickiAS, et al.Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy. Obstet Gynecol2006; 107: 106–114.
26.
MartineauMGRakerCDixonPH, et al.The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growth. Diabetes Care2015; 38: 243–248.
27.
OvadiaCSeedPTSklavounosA, et al.Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet2019; 393: 899–909.
28.
WalkerKFChappellLCHagueWM, et al.Pharmacological interventions for treating intrahepatic cholestasis of pregnancy. Cochrane Database Syst Rev2020; 2020. doi: 10.1002/14651858.CD000493.pub3
29.
OvadiaCSajousJSeedPT, et al.Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: systematic review and individual participant data meta-analysis. Lancet Gastroenterol Hepatol2021; 6: 547–558.
30.
MannaLBOvadiaCLovgren-SandblomA, et al.Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study. BJOG2019; 126: 1633–1640.
31.
LiQDuttaAKresgeC, et al.Bile acids stimulate cholangiocyte fluid secretion by activation of the transmembrane member 16A CI(-) channels. Hepatology2018; 68: 187–199.
32.
HagueWMCallawayLChambersJ, et al.A multicentre, open-label, randomised, parallel-group, superiority trial to compare the efficacy of Ursodeoxycholic acid with Rifampicin in the management of women with severe early-onset intrahepatic cholestasis of pregnancy: the TURRIFIC randomised trial. BMC Pregnancy Childbirth2021; 21: 51.
33.
ZimmermanPKoskinenJVaalamoP, et al.Doppler Umbilical artery velocity in pregnancies complicated by intrahepatic cholestasis. J Perinat Med1991; 19: 351–355.
34.
BacqYSapeyTBrechotM, et al.Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology1997; 26: 358–364.
35.
FurrerRWinterKSchafferL, et al.Postpartum loss in women treated for intrahepatic cholestasis of pregnancy. Obstet Gynecol2016; 128: 1048–1052.
36.
Wikstrom ShemerEAStephanssonOThuressonM, et al.Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: a population-based cohort study. J Hepatol2015; 63: 456–461.
37.
HuangLLiXLiuT, et al.Effect of intrahepatic cholestasis of pregnancy on infantile food allergy: a retrospective longitudinal study cohort in Southwest China. Eur J Obstet Gynecol Reprod Biol2022; 272: 110.
38.
PapacleovoulouGAbu-HayyehSNikolopoulouE, et al.Maternal cholestasis during pregnancy programs metabolic disease in offspring. J Cin Invest2013; 123: 3172–3181.
